• About
  • Pipeline
    • IBIO-101
    • IBIO-100
    • IBIO-400
  • Platform
  • Media/Events
    • Press Releases
    • In the News
    • Events
  • Careers
  • Investors
  • Contact
Investors

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Profile
    • Management Team
    • Presentations
  • News & Events
    • Press Releases
    • IR Calendar
  • Stock Data
    • Quote
    • Historical Data
  • SEC Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQ
  • News & Events

  • Press Releases
  • IR Calendar
Jan 05, 2023 8:00am EST

iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine

Dec 09, 2022 4:05pm EST

iBio Announces Closing of $3.5 Million Underwritten Public Offering

Dec 06, 2022 11:27pm EST

iBio Announces Pricing of $3.5 Million Underwritten Public Offering

Dec 06, 2022 4:01pm EST

iBio Announces Proposed Underwritten Public Offering

Dec 06, 2022 8:00am EST

iBio to Participate in the JMP Securities Hematology and Oncology Summit

Dec 05, 2022 8:00am EST

iBio® to Showcase the RubrYc® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022

Dec 02, 2022 4:30pm EST

iBio Announces CEO Departure

Nov 03, 2022 8:00am EDT

iBio Accelerates Transformation to AI-Powered Biotech

Sep 27, 2022 4:10pm EDT

iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update

Sep 21, 2022 8:30am EDT

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …16
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Home
  • About
  • Pipeline
  • Platform
  • Media/Events
  • Careers
  • Investors
  • Contact

Headquarters

8800 HSC Pkwy
Bryan, TX 77807

Research & Development

11750 Sorrento Valley Road
Suite 200
San Diego, CA 92121

(979) 446-0027
LinkedIn
info@ibioinc.com
RSS News Feed
© 2022 iBio, Inc. All Rights Reserved.
Privacy Policy. Terms and Conditions. TiC Public Disclosure.